Stanford trial seeks best Vision-Saving corneal transplant
NCT ID NCT05289661
Summary
This study aims to find out which of two modern corneal transplant surgeries works better for people with Fuchs' dystrophy, a condition that clouds the clear front part of the eye. It will also test if adding a specific eye drop medication helps preserve the health of the transplanted cells. The trial involves 160 participants and will measure their vision and cell health one year after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03766, United States
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Stanford University
Palo Alto, California, 94303, United States
-
University of California Davis
Sacramento, California, 95817, United States
-
University of Miami
Palm Beach Gardens, Florida, 33418, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
Wills Eye Hospital
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.